A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway - PubMed (original) (raw)
. 2007 Apr 24;46(16):4716-24.
doi: 10.1021/bi061928s. Epub 2007 Mar 31.
Osnat Ohne, Shirly Ben-Yaakov, Liron Shemesh-Darvish, Tamar Yechezkel, Yosef Salitra, Shai Rubnov, Ilana Cohen, Hanoch Senderowitz, Dvora Kidron, Oded Livnah, Alexander Levitzki, Nurit Livnah
Affiliations
- PMID: 17397140
- DOI: 10.1021/bi061928s
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway
Pninit Litman et al. Biochemistry. 2007.
Abstract
We describe a novel, potent peptide substrate mimetic inhibitor of protein kinase B (PKB/Akt). The compound selectively kills prostate cancer cells, in which PKB is highly activated, but not normal cells, or cancer cells in which PKB is not activated. The inhibitor induces apoptosis and inhibits the phosphorylation of PKB substrates in prostate cancer cell lines and significantly increases the efficacy of chemotherapy agents to induce prostate cancer cell death, when given in combination. In vivo, the inhibitor exhibits a strong antitumor effect in two prostate cancer mouse models. Moreover, treated animals develop significantly less lung metastases compared to untreated ones, and the effect is accompanied by a significant decrease in blood PSA [prostate-specific antigen] levels in treated animals. This compound and its potential analogues may be developed into novel, potent, and safe anticancer agents, both as stand-alone treatment and in combination with other chemotherapy agents.
Similar articles
- Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP).
Zhang M, Fang X, Liu H, Wang S, Yang D. Zhang M, et al. Biochem Pharmacol. 2007 Jan 1;73(1):15-24. doi: 10.1016/j.bcp.2006.07.034. Epub 2006 Sep 1. Biochem Pharmacol. 2007. PMID: 16950208 - Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Lincová E, Hampl A, Pernicová Z, Starsíchová A, Krcmár P, Machala M, Kozubík A, Soucek K. Lincová E, et al. Biochem Pharmacol. 2009 Sep 15;78(6):561-72. doi: 10.1016/j.bcp.2009.05.001. Epub 2009 May 9. Biochem Pharmacol. 2009. PMID: 19433066 - Protein kinase B: signalling roles and therapeutic targeting.
Sale EM, Sale GJ. Sale EM, et al. Cell Mol Life Sci. 2008 Jan;65(1):113-27. doi: 10.1007/s00018-007-7274-9. Cell Mol Life Sci. 2008. PMID: 17952368 Free PMC article. Review. - Fragment-based discovery of inhibitors of protein kinase B.
Davies TG, Woodhead SJ, Collins I. Davies TG, et al. Curr Top Med Chem. 2009;9(18):1705-17. doi: 10.2174/156802609790102419. Curr Top Med Chem. 2009. PMID: 19929839 Review.
Cited by
- The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance.
Biswas B, Huang YH, Craik DJ, Wang CK. Biswas B, et al. Chem Sci. 2024 Jul 13;15(33):13130-13147. doi: 10.1039/d4sc01088d. eCollection 2024 Aug 22. Chem Sci. 2024. PMID: 39183924 Free PMC article. Review. - Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design.
Düzgüneş N, Fernandez-Fuentes N, Konopka K. Düzgüneş N, et al. Pathogens. 2021 Dec 9;10(12):1599. doi: 10.3390/pathogens10121599. Pathogens. 2021. PMID: 34959554 Free PMC article. Review. - Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!
Rubin SJS, Tal-Gan Y, Gilon C, Qvit N. Rubin SJS, et al. Curr Top Med Chem. 2018;18(7):556-565. doi: 10.2174/1568026618666180518094322. Curr Top Med Chem. 2018. PMID: 29773063 Free PMC article. Review. - Imidazo[1,2-a]pyridine-based peptidomimetics as inhibitors of Akt.
Kim YB, Kang CW, Ranatunga S, Yang H, Sebti SM, Del Valle JR. Kim YB, et al. Bioorg Med Chem Lett. 2014 Oct 1;24(19):4650-4653. doi: 10.1016/j.bmcl.2014.08.040. Epub 2014 Aug 28. Bioorg Med Chem Lett. 2014. PMID: 25205195 Free PMC article. - Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation.
Nguyen T, Coover RA, Verghese J, Moran RG, Ellis KC. Nguyen T, et al. ACS Med Chem Lett. 2014 Mar 7;5(5):462-7. doi: 10.1021/ml500088x. eCollection 2014 May 8. ACS Med Chem Lett. 2014. PMID: 24900862 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous